I-Mab (NASDAQ:IMAB) Q2 2023 Earnings Call Transcript August 17, 2023 Tyler Ehler: Good morning, everyone, and thank you for joining us this morning and for standing by. I’d like to take this opportunity to welcome you all to the I-Mab Biopharma Mid-Year 2023 Financial Results and Business Update Conference Call. My name is Tyler Ehler, […]
I-Mab Biopharma (IMAB) Provides Business Update, Report H1 22 Results streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
There’s no shortage of market-moving news these days about up-and-coming cancer drug maker I-Mab, whose stock is getting pulled every which way as a result. Read more on IMAB stock.
- Biotech and Wall Street veteran Mr. Richard Yeh to focus on strategic investor interactions, global alliance management and facilities as COO - Renowned oncology expert Dr.. | April 28, 2022